Alessia Di Costanzo

Publications

Title Published on Year
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification ATHEROSCLEROSIS 2022
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis BIOCHIMICA AND BIOPHYSICA ACTA. MOLECULAR AND CELL BIOLOGY OF LIPIDS 2022
Twelve variants polygenic score for low-density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with or without causative mutations JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2022
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4 NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2022
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2022
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells CLINICAL AND EXPERIMENTAL IMMUNOLOGY 2022
The interplay between angiopoietin-like proteins and adipose tissue: Another piece of the relationship between adiposopathy and cardiometabolic diseases? INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and Adolescents JOURNAL OF PEDIATRICS 2021
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD) BIOMEDICINES 2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis JOURNAL OF CLINICAL LIPIDOLOGY 2021
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey ORPHANET JOURNAL OF RARE DISEASES 2021
Clinical implications of monogenic versus polygenic hypercholesterolemia: Long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2021
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells CLINICAL AND EXPERIMENTAL IMMUNOLOGY 2021
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2021
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and Adolescents. THE JOURNAL OF PEDIATRICS 2021
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events. JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2021
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey ORPHANET JOURNAL OF RARE DISEASES 2021
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: a retrospective, single center, observational study NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2020
Hdl-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (Nafld) BIOMEDICINES 2020
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma